These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 3934576)

  • 1. Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin.
    Kalivas PW; Bronson M
    Neuropharmacology; 1985 Oct; 24(10):931-6. PubMed ID: 3934576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity.
    Kalivas PW; Widerlöv E; Stanley D; Breese G; Prange AJ
    J Pharmacol Exp Ther; 1983 Oct; 227(1):229-37. PubMed ID: 6620168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II. Involvement of the mesolimbic dopamine system.
    Kalivas PW
    J Pharmacol Exp Ther; 1985 Nov; 235(2):544-50. PubMed ID: 4057084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sensitization between foot shock stress and enkephalin-induced motor activity.
    Kalivas PW; Richardson-Carlson R; Van Orden G
    Biol Psychiatry; 1986 Aug; 21(10):939-50. PubMed ID: 3741911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine.
    Kalivas PW; Abhold R
    Brain Res; 1987 Jun; 414(2):339-48. PubMed ID: 3620936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intra-accumbens dopaminergic grafts on behavioral deficits induced by 6-OHDA lesions of the nucleus accumbens or A10 dopaminergic neurons: a comparison.
    Herman JP; Choulli K; Abrous N; Dulluc J; Le Moal M
    Behav Brain Res; 1988 Jul; 29(1-2):73-83. PubMed ID: 3401324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer.
    Phillips GD; Robbins TW; Everitt BJ
    Psychopharmacology (Berl); 1994 Mar; 114(2):345-59. PubMed ID: 7838928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-accumbens implants of embryonic dopaminergic neurons reverse the behavioral supersensitivity to opiates evoked by lesion of the mesolimbic dopaminergic pathway.
    Abrous DN; Stinus L; Le Moal M; Herman JP
    Brain Res; 1990 Aug; 525(1):155-9. PubMed ID: 2245321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin microinjection into the nucleus accumbens antagonizes dopamine-induced increase in locomotion and rearing.
    Kalivas PW; Nemeroff CB; Prange AJ
    Neuroscience; 1984 Apr; 11(4):919-30. PubMed ID: 6738859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesolimbic dopamine projection modulates amygdala-evoked EPSP in nucleus accumbens neurons: an in vivo study.
    Yim CY; Mogenson GJ
    Brain Res; 1986 Mar; 369(1-2):347-52. PubMed ID: 3008939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternation behavior, spatial discrimination, and reversal disturbances following 6-hydroxydopamine lesions in the nucleus accumbens of the rat.
    Taghzouti K; Louilot A; Herman JP; Le Moal M; Simon H
    Behav Neural Biol; 1985 Nov; 44(3):354-63. PubMed ID: 3936470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and biochemical effects of intra-accumbens dopaminergic grafts.
    Ishida Y; Hashitani T; Kumazaki M; Ikeda T; Nishino H
    Brain Res Bull; 1990 Mar; 24(3):487-92. PubMed ID: 2110848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. d-Ala-met-enkephalin injection into the ventral tegmental area: effect on investigatory and spontaneous motor behaviour in the rat.
    Cador M; Kelley AE; Le Moal M; Stinus L
    Psychopharmacology (Berl); 1988; 96(3):332-42. PubMed ID: 3146768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance P modulation of the mesolimbic dopamine system.
    Kalivas P
    Prog Clin Biol Res; 1985; 192():403-8. PubMed ID: 2417255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. I. Behavioral characterization.
    Kalivas PW; Taylor S; Miller JS
    J Pharmacol Exp Ther; 1985 Nov; 235(2):537-43. PubMed ID: 2865357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of CCK immunoreactivity and dopamine in the nucleus accumbens after 6-hydroxydopamine lesions of the ventral tegmental area and the nucleus accumbens.
    Igarashi Y; Wiegant VM; Van Ree JM
    Neuropeptides; 1989; 14(2):71-6. PubMed ID: 2812290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system.
    French ED; Pilapil C; Quirion R
    Eur J Pharmacol; 1985 Oct; 116(1-2):1-9. PubMed ID: 2996909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperactivity and hypoactivity produced by lesions to the mesolimbic dopamine system.
    Koob GF; Stinus L; Le Moal M
    Behav Brain Res; 1981 Nov; 3(3):341-59. PubMed ID: 6796098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between D-ala-met-enkephalin, A10 dopaminergic neurones, and spontaneous behaviour in the rat.
    Kelley AE; Stinus L; Iversen SD
    Behav Brain Res; 1980 Feb; 1(1):3-24. PubMed ID: 6269560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ventro-medial mesencephalic tegmentum (VMT) stimulation on the spontaneous activity of nucleus accumbens neurones: influence of the dopamine system.
    Le Douarin C; Penit J; Glowinski J; Thierry AM
    Brain Res; 1986 Jan; 363(2):290-8. PubMed ID: 3002556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.